Wednesday 1 March 2017

British Cycling Statement


BRITISH CYCLING STATEMENT

British Cycling welcomes the comments of UKAD chief executive Nicole Sapstead and would like to thank her and other UKAD staff for their work.

We have cooperated fully with UKAD throughout this process and we have encouraged others to do the same.

We acknowledge serious failings in our record keeping at the time. Our medicines management processes have been reviewed several times since 2011 and, through working with UKAD in recent months, we have identified further areas for improvement on this and in the provision of our wider medical services.

As has already been reported, Dr Richard Freeman is currently unwell. British Cycling owes a duty of care to him as his employer and therefore we will not make any further comment at this time.

British Cycling chair Jonathan Browning said: “Following the comments from UKAD chief executive Nicole Sapstead, we can announce the following measures to address clear failings in our processes highlighted in the investigation:

“First, an audit of our medical services provided to the Great Britain Cycling Team – we have taken the initial steps to enable the Care Quality Commission to examine the medical support we offer to our athletes and to identify areas of improvement.

“Second, a further review of the Great Britain Cycling Team’s medicines management policy – we will be seeking UKAD support in this.

“At British Cycling, we are wholly committed to clean sport and I want to assure athletes, fans and all other stakeholders that this commitment is unwavering.

“For anyone lucky enough to be working in any sport, it is not enough to just be clean, we must also be able to demonstrate that we are clean with transparent and accountable processes including good record-keeping and solid policies on all areas of medical support.

“This is a fundamental responsibility, rooted in our duty to the athletes in our care as well as in our duty to the sport, and one which we take extremely seriously.”


No comments:

Post a Comment